Literature DB >> 4707178

The Bedford glaucoma survey. I. Long-term follow-up of borderline cases.

E S Perkins.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4707178      PMCID: PMC1215412          DOI: 10.1136/bjo.57.3.179

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  2 in total

1.  Ocular pressure and visual fields. A ten-year follow-up study.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1969-01

2.  The definition of pre-glaucoma. A prospective study.

Authors:  P A Graham
Journal:  Trans Ophthalmol Soc U K       Date:  1969
  2 in total
  24 in total

1.  Glaucoma screening: too little, too late?

Authors:  A Sommer
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Characteristics of manifest glaucoma at early stages.

Authors:  B Bengtsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Family studies in glaucoma.

Authors:  E S Perkins
Journal:  Br J Ophthalmol       Date:  1974-05       Impact factor: 4.638

4.  Screening for glaucoma.

Authors: 
Journal:  Br Med J       Date:  1973-09-08

5.  Inadequate diagnostic value of the water-drinking test.

Authors:  J A Roth
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

6.  Ocular hypertension--a long-term follow-up of treated and untreated patients.

Authors:  R David; D G Livingston; M H Luntz
Journal:  Br J Ophthalmol       Date:  1977-11       Impact factor: 4.638

7.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

8.  Ocular hypertension.

Authors: 
Journal:  Br Med J       Date:  1978-05-13

9.  Family studies in glaucoma.

Authors:  A R Rosenthal; E S Perkins
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

10.  Lateral differences indicate future glaucoma.

Authors:  A Thölen; L Tremmel; W Maurer; Y Robert; P Hendrickson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.